Global and United States Direct-to-consumer Disease Risk and Health Test Market Report & Forecast 2022-2028

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
Market Analysis and Insights: Global and United States Direct-to-consumer Disease Risk and Health Test Market
This report focuses on global and United States Direct-to-consumer Disease Risk and Health Test market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Direct-to-consumer Disease Risk and Health Test market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Celiac Disease accounting for % of the Direct-to-consumer Disease Risk and Health Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Online was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Direct-to-consumer Disease Risk and Health Test market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Direct-to-consumer Disease Risk and Health Test Scope and Market Size
Direct-to-consumer Disease Risk and Health Test market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Direct-to-consumer Disease Risk and Health Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Direct-to-consumer Disease Risk and Health Test market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other
Segment by Application
Online
Offline
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes